Dow Up 1.44% Nasdaq Up 1.61%

Celsion Corp. (CLSN)

-NasdaqCM
2.57 Up 0.03(1.18%) 2:40PM EDT - Nasdaq Real Time Price
Prev Close:2.54
Open:2.52
Bid:2.55 x 300
Ask:2.58 x 2300
1y Target Est:8.00
Beta:1.85
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:2.43 - 2.58
52wk Range:2.38 - 5.90
Volume:90,157
Avg Vol (3m):100,383
Market Cap:51.29M
P/E (ttm):N/A
EPS (ttm):-1.21
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CLSN

Comparison

Symbol% ChgMkt Cap
CLSNUp 1.18%51.29M
BSDMDown 9.26%19.45M
DCTHUp 2.34%16.53M
MMSIUp 0.47%555.05M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):101.39
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.33
Quarterly EPS Est (Sep-14) :-0.32
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Celsion Corporation, an oncology drug development company, focuses on the development and commercialization of chemotherapeutic oncology drugs based on its proprietary heat-activated liposomal technology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback